Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
J Peripher Nerv Syst. 2023 Sep;28(3):518-521. doi: 10.1111/jns.12567. Epub 2023 Jun 7.
Pathogenic variants of HSPB1, the gene encoding the small heat shock protein 27, have been reported to cause autosomal dominant distal hereditary motor neuropathy (dHMN) type II and autosomal dominant Charcot-Marie-Tooth (CMT) disease with minimal sensory involvement (CMT2F). This study aimed to describe the clinical features of patients in a family with late-onset dHMN carrying the Pro39Leu variant of HSPB1.
Whole-exome sequence analysis identified a heterozygous pathogenic variant (Pro39Leu) of HSPB1 in the proband. The presence of the HSPB1 Pro39Leu variant in two affected individuals was confirmed using direct nucleotide sequence analysis.
Both patients exhibited distal muscle weakness with lower extremity predominance and no obvious sensory deficits, leading to a clinical diagnosis of late-onset dHMN. Nerve conduction studies (NCSs) revealed a subclinical complication of sensory disturbance in one of the patients. The clinical and electrophysiological findings of patients with the HSPB1 Pro39Leu variant in this study and previous reports are summarized.
This study suggests that the clinical spectrum of patients carrying HSPB1 Pro39Leu variants, especially the disease onset, might be broader than expected, and HSPB1 variants should be considered in patients diagnosed with late-onset dHMN. Furthermore, patients with dHMN may have concomitant sensory deficits that should be evaluated using NCSs.
HSPB1 基因(编码小热休克蛋白 27)的致病性变异可导致常染色体显性遗传性远端运动神经病(dHMN)Ⅱ型和常染色体显性遗传性感觉运动神经病伴最小感觉受累(CMT2F)。本研究旨在描述携带 HSPB1 Pro39Leu 变异的晚发性 dHMN 家系患者的临床特征。
对先证者进行全外显子组测序,发现 HSPB1 存在杂合致病性变异(Pro39Leu)。采用直接核苷酸序列分析,在两名受累个体中证实了 HSPB1 Pro39Leu 变异的存在。
两名患者均表现为以下肢为主的远端肌无力,无明显感觉缺失,临床诊断为晚发性 dHMN。神经传导研究(NCSs)显示其中一名患者存在感觉障碍的亚临床并发症。总结了本研究和以往报道中 HSPB1 Pro39Leu 变异患者的临床和电生理表现。
本研究表明,携带 HSPB1 Pro39Leu 变异的患者的临床表型谱,尤其是发病年龄,可能比预期的更广泛,应考虑 HSPB1 变异在晚发性 dHMN 患者中的存在。此外,dHMN 患者可能存在感觉缺失,应使用 NCSs 进行评估。